Lahiri Anupam, Yadav Vishal, Arora Vikas, Sharma Prerit, Dewan A K
Department of Surgical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
Endocrine. 2025 May;88(2):564-570. doi: 10.1007/s12020-024-04158-8. Epub 2025 Jan 8.
Intraoperative parathyroid gland (PG) localization remains challenging during thyroid surgeries, contributing to postoperative hypocalcemia and hypoparathyroidism. This study assessed the efficacy of indocyanine green (ICG) fluorescence in identifying and preserving PGs during thyroid surgeries and its correlation with postoperative outcomes.
This ambispective observational study included 57 patients undergoing thyroid surgeries using ICG and compared outcomes with 56 historical controls. ICG was administered intravenously in two 5 mg boluses. Parathyroid identification rates, fluorescence intensity, and postoperative calcium and parathormone levels were assessed. Fluorescence intensity was qualitatively scored on a 1-3 scale.
ICG significantly improved PG identification (92.5% vs 69.3% with white light alone). Postoperative hypocalcemia occurred in 22.81% of ICG patients compared to 39.29% in controls (p = 0.045). Hypoparathyroidism rates were 10.53% and 32.14% respectively (p = 0.005). Higher fluorescence intensity (FI) correlated with lower risk of postoperative hypocalcemia (p = 0.026) and combined hypocalcemia and hypoparathyroidism (p = 0.046). Considering both FI 2 and 3 as positive yielded 100% sensitivity and 85.7% accuracy. When only FI 3 was considered positive, sensitivity was 78.4%, specificity was 50%, and accuracy was 69.4%.
ICG fluorescence is a safe and effective tool for enhancing PG identification and preservation in thyroid surgeries, significantly reducing postoperative hypocalcemia and hypoparathyroidism. It also helps in confirming the vascularity of the PGs post thyroidectomy. Fluorescence intensity of preserved PGs, rather than quantity, better predicts postoperative outcomes. These findings support the integration of ICG fluorescence imaging and the application of our methodology in thyroid surgeries to improve postoperative results.
在甲状腺手术中,术中甲状旁腺(PG)定位仍然具有挑战性,这会导致术后低钙血症和甲状旁腺功能减退。本研究评估了吲哚菁绿(ICG)荧光在甲状腺手术中识别和保留甲状旁腺的有效性及其与术后结果的相关性。
这项双前瞻性观察性研究纳入了57例使用ICG进行甲状腺手术的患者,并将结果与56例历史对照进行比较。ICG以两次5mg推注的方式静脉给药。评估甲状旁腺识别率、荧光强度以及术后钙和甲状旁腺激素水平。荧光强度按1 - 3级进行定性评分。
ICG显著提高了甲状旁腺的识别率(92.5%对比仅用白光时的69.3%)。ICG组患者术后低钙血症发生率为22.81%,而对照组为39.29%(p = 0.045)。甲状旁腺功能减退率分别为10.53%和32.14%(p = 0.005)。较高的荧光强度(FI)与较低的术后低钙血症风险(p = 0.026)以及低钙血症和甲状旁腺功能减退合并症风险(p = 0.046)相关。将FI 2和3都视为阳性时,敏感性为100%,准确性为85.7%。仅将FI 3视为阳性时,敏感性为78.4%,特异性为50%,准确性为69.4%。
ICG荧光是一种安全有效的工具,可增强甲状腺手术中甲状旁腺的识别和保留,显著降低术后低钙血症和甲状旁腺功能减退。它还有助于确认甲状腺切除术后甲状旁腺的血管情况。保留的甲状旁腺的荧光强度而非数量能更好地预测术后结果。这些发现支持将ICG荧光成像和我们的方法应用于甲状腺手术以改善术后结果。